The Weston family, via its holding company Wittington Investments, has completed an $8.9bn (£6.74bn) purchase of Boots, the UK’s leading pharmacy and beauty retailer.

Deal value and assets transferred

The transaction gives the Canadian conglomerate control of Boots’ UK and Irish retail stores, its opticians chain, the No7 beauty brand and a franchise operation in Thailand. The price, announced on Friday, reflects a premium over the retailer’s last‑year valuation.

Strategic rationale

Wittington, which already owns the Loblaws grocery chain and the Shoppers Drug Mart pharmacy network, said the acquisition fits a long‑term plan to build a trans‑Atlantic retail platform. Integrating Boots with Shoppers Drug Mart could enable shared sourcing, digital services and loyalty programmes across the two markets.

Market reaction and analyst view

London‑listed shares in Boots’ parent company rose modestly after the deal was disclosed, while analysts noted the move strengthens the Weston portfolio at a time when UK high‑street retailers face declining footfall. They highlighted the potential for cost synergies and the opportunity to revive Boots’ beauty segment, which has struggled against online rivals.

Implications for the high street and shoppers

Industry observers expect the new owners to invest in store refurbishments and digital ordering, aiming to preserve jobs while modernising the brand. Customers may see an expanded No7 product range and tighter integration with Shoppers Drug Mart’s health services, although any restructuring could affect staffing levels in the short term.

Regulatory approval from the UK Competition and Markets Authority is still pending, with a decision expected by the end of the year. Completion of the integration plan is slated for early 2027, when the Weston family will formally announce its strategic roadmap for Boots.